HK Stock MarketDetailed Quotes

CSPC PHARMA (01093)

Watchlist

9.750
-0.050-0.51%

Trading Jan 16 14:34 CST

112.34BMarket Cap25.26P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CSPC PHARMA (01093) Income Statement

All

YOY

Hide blank lines

(Q9)Sep 30, 2025

(Q6)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

Turnover

-12.32%19.89B

-18.49%13.27B

-21.91%7.01B

-7.76%29.01B

-4.94%22.69B

1.27%16.28B

11.54%8.98B

1.66%31.45B

1.57%23.87B

3.01%16.08B

Operating income

-12.32%19.89B

-18.49%13.27B

-21.91%7.01B

-7.76%29.01B

-4.94%22.69B

1.27%16.28B

11.54%8.98B

1.66%31.45B

1.57%23.87B

3.01%16.08B

Cost of sales

-2.11%-6.84B

1.44%-4.56B

7.15%-2.31B

6.07%-8.71B

5.26%-6.7B

4.40%-4.63B

1.87%-2.49B

-6.83%-9.27B

-10.29%-7.07B

-13.37%-4.84B

Operating expenses

-2.11%-6.84B

1.44%-4.56B

7.15%-2.31B

6.07%-8.71B

5.26%-6.7B

4.40%-4.63B

1.87%-2.49B

-6.83%-9.27B

-10.29%-7.07B

-13.37%-4.84B

Gross profit

-18.37%13.05B

-25.26%8.71B

-27.56%4.71B

-8.47%20.3B

-4.80%15.99B

3.71%11.65B

17.70%6.5B

-0.36%22.18B

-1.70%16.79B

-0.89%11.24B

Selling expenses

27.58%-4.8B

36.18%-3.05B

43.90%-1.66B

5.23%-8.66B

5.79%-6.62B

2.55%-4.78B

-18.97%-2.96B

11.58%-9.14B

13.34%-7.03B

9.39%-4.9B

Administrative expenses

29.60%-619.98M

36.52%-401.72M

31.37%-228.44M

9.25%-1.08B

-2.88%-880.65M

-18.15%-632.84M

-26.51%-332.83M

-1.43%-1.19B

2.08%-855.97M

5.17%-535.64M

Research and development expenses

-7.87%-4.19B

-5.53%-2.68B

-11.37%-1.3B

-7.46%-5.19B

-5.49%-3.88B

-10.35%-2.54B

-16.04%-1.17B

-21.17%-4.83B

-25.95%-3.68B

-22.27%-2.3B

Profit from asset sales

----

--32.86M

----

Special items of operating profit

257.35%927.55M

233.62%575.4M

371.54%278.47M

-17.80%345.73M

-36.05%259.57M

-19.70%172.47M

41.09%59.06M

-48.38%420.59M

-8.36%405.88M

-13.72%214.78M

Operating profit

-10.00%4.37B

-18.65%3.15B

-14.35%1.79B

-23.53%5.71B

-13.72%4.86B

4.42%3.87B

16.13%2.09B

-1.39%7.47B

0.27%5.63B

-0.47%3.71B

Financing cost

4.36%-31.84M

1.47%-21.65M

-10.38%-6.74M

-68.65%-43.67M

-97.26%-33.29M

-104.95%-21.98M

-37.84%-6.11M

-4.04%-25.9M

-12.51%-16.88M

-10.29%-10.72M

Share of profits of associates

17.55%-32.6M

46.00%-14.71M

111.85%1.78M

-11.83%-45.92M

-19.90%-39.53M

-67.65%-27.24M

-24.61%-15.01M

3.40%-41.07M

29.06%-32.97M

39.72%-16.25M

Share of profit from joint venture company

83.32%-6.91M

107.94%1.94M

162.21%8.39M

-231.67%-43.55M

-653.04%-41.44M

-983.37%-24.43M

-187.38%-13.48M

-148.43%-13.13M

-113.24%-5.5M

-108.12%-2.26M

Special items of earning before tax

----

--32.86M

----

Earning before tax

-9.33%4.3B

-17.98%3.12B

-12.74%1.8B

-24.50%5.58B

-15.41%4.75B

3.25%3.8B

15.57%2.06B

-2.54%7.39B

0.23%5.61B

-1.02%3.68B

Tax

18.74%-766.09M

27.49%-543.62M

29.67%-301.26M

5.83%-1.24B

2.28%-942.7M

-20.23%-749.66M

-37.35%-428.35M

2.48%-1.32B

5.98%-964.74M

9.95%-623.51M

After-tax profit from continuing operations

-7.00%3.54B

-15.65%2.57B

-8.29%1.49B

-28.55%4.34B

-18.13%3.8B

-0.21%3.05B

10.94%1.63B

-2.56%6.07B

1.62%4.65B

1.02%3.06B

Earning after tax

-7.00%3.54B

-15.65%2.57B

-8.29%1.49B

-28.55%4.34B

-18.13%3.8B

-0.21%3.05B

10.94%1.63B

-2.56%6.07B

1.62%4.65B

1.02%3.06B

Minority profit

1.13%25.05M

-15.74%26.2M

-1.33%16.81M

-94.59%10.79M

-83.53%24.77M

-65.85%31.09M

-57.68%17.04M

41.74%199.37M

45.84%150.38M

49.57%91.05M

Profit attributable to shareholders

-7.06%3.51B

-15.64%2.55B

-8.36%1.48B

-26.31%4.33B

-15.94%3.78B

1.80%3.02B

12.88%1.61B

-3.58%5.87B

0.60%4.49B

0.03%2.97B

Basic earnings per share

-4.09%0.3072

-12.62%0.2229

-5.14%0.1291

-25.47%0.3687

-15.35%0.3203

2.24%0.2551

13.51%0.1361

-3.21%0.4947

0.93%0.3784

0.24%0.2495

Diluted earnings per share

-4.09%0.3072

-12.62%0.2229

-5.14%0.1291

-25.47%0.3687

-15.33%0.3203

2.24%0.2551

13.51%0.1361

-3.21%0.4947

0.91%0.3783

0.24%0.2495

Currency Unit

CNY

Accounting Standards

HKAS

Audit Opinions

Unqualified Opinion

Auditor

Deloitte Guan Huang Chen Fang Certified Public Accountants

Deloitte Touche Tohmatsu

	(Q9)Sep 30, 2025	(Q6)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023
Turnover	-12.32%19.89B	-18.49%13.27B	-21.91%7.01B	-7.76%29.01B	-4.94%22.69B	1.27%16.28B	11.54%8.98B	1.66%31.45B	1.57%23.87B	3.01%16.08B
Operating income	-12.32%19.89B	-18.49%13.27B	-21.91%7.01B	-7.76%29.01B	-4.94%22.69B	1.27%16.28B	11.54%8.98B	1.66%31.45B	1.57%23.87B	3.01%16.08B
Cost of sales	-2.11%-6.84B	1.44%-4.56B	7.15%-2.31B	6.07%-8.71B	5.26%-6.7B	4.40%-4.63B	1.87%-2.49B	-6.83%-9.27B	-10.29%-7.07B	-13.37%-4.84B
Operating expenses	-2.11%-6.84B	1.44%-4.56B	7.15%-2.31B	6.07%-8.71B	5.26%-6.7B	4.40%-4.63B	1.87%-2.49B	-6.83%-9.27B	-10.29%-7.07B	-13.37%-4.84B
Gross profit	-18.37%13.05B	-25.26%8.71B	-27.56%4.71B	-8.47%20.3B	-4.80%15.99B	3.71%11.65B	17.70%6.5B	-0.36%22.18B	-1.70%16.79B	-0.89%11.24B
Selling expenses	27.58%-4.8B	36.18%-3.05B	43.90%-1.66B	5.23%-8.66B	5.79%-6.62B	2.55%-4.78B	-18.97%-2.96B	11.58%-9.14B	13.34%-7.03B	9.39%-4.9B
Administrative expenses	29.60%-619.98M	36.52%-401.72M	31.37%-228.44M	9.25%-1.08B	-2.88%-880.65M	-18.15%-632.84M	-26.51%-332.83M	-1.43%-1.19B	2.08%-855.97M	5.17%-535.64M
Research and development expenses	-7.87%-4.19B	-5.53%-2.68B	-11.37%-1.3B	-7.46%-5.19B	-5.49%-3.88B	-10.35%-2.54B	-16.04%-1.17B	-21.17%-4.83B	-25.95%-3.68B	-22.27%-2.3B
Profit from asset sales	----	----	----	----	----	----	----	--32.86M	----	----
Special items of operating profit	257.35%927.55M	233.62%575.4M	371.54%278.47M	-17.80%345.73M	-36.05%259.57M	-19.70%172.47M	41.09%59.06M	-48.38%420.59M	-8.36%405.88M	-13.72%214.78M
Operating profit	-10.00%4.37B	-18.65%3.15B	-14.35%1.79B	-23.53%5.71B	-13.72%4.86B	4.42%3.87B	16.13%2.09B	-1.39%7.47B	0.27%5.63B	-0.47%3.71B
Financing cost	4.36%-31.84M	1.47%-21.65M	-10.38%-6.74M	-68.65%-43.67M	-97.26%-33.29M	-104.95%-21.98M	-37.84%-6.11M	-4.04%-25.9M	-12.51%-16.88M	-10.29%-10.72M
Share of profits of associates	17.55%-32.6M	46.00%-14.71M	111.85%1.78M	-11.83%-45.92M	-19.90%-39.53M	-67.65%-27.24M	-24.61%-15.01M	3.40%-41.07M	29.06%-32.97M	39.72%-16.25M
Share of profit from joint venture company	83.32%-6.91M	107.94%1.94M	162.21%8.39M	-231.67%-43.55M	-653.04%-41.44M	-983.37%-24.43M	-187.38%-13.48M	-148.43%-13.13M	-113.24%-5.5M	-108.12%-2.26M
Special items of earning before tax	----	----	----	----	----	----	----	----	--32.86M	----
Earning before tax	-9.33%4.3B	-17.98%3.12B	-12.74%1.8B	-24.50%5.58B	-15.41%4.75B	3.25%3.8B	15.57%2.06B	-2.54%7.39B	0.23%5.61B	-1.02%3.68B
Tax	18.74%-766.09M	27.49%-543.62M	29.67%-301.26M	5.83%-1.24B	2.28%-942.7M	-20.23%-749.66M	-37.35%-428.35M	2.48%-1.32B	5.98%-964.74M	9.95%-623.51M
After-tax profit from continuing operations	-7.00%3.54B	-15.65%2.57B	-8.29%1.49B	-28.55%4.34B	-18.13%3.8B	-0.21%3.05B	10.94%1.63B	-2.56%6.07B	1.62%4.65B	1.02%3.06B
Earning after tax	-7.00%3.54B	-15.65%2.57B	-8.29%1.49B	-28.55%4.34B	-18.13%3.8B	-0.21%3.05B	10.94%1.63B	-2.56%6.07B	1.62%4.65B	1.02%3.06B
Minority profit	1.13%25.05M	-15.74%26.2M	-1.33%16.81M	-94.59%10.79M	-83.53%24.77M	-65.85%31.09M	-57.68%17.04M	41.74%199.37M	45.84%150.38M	49.57%91.05M
Profit attributable to shareholders	-7.06%3.51B	-15.64%2.55B	-8.36%1.48B	-26.31%4.33B	-15.94%3.78B	1.80%3.02B	12.88%1.61B	-3.58%5.87B	0.60%4.49B	0.03%2.97B
Basic earnings per share	-4.09%0.3072	-12.62%0.2229	-5.14%0.1291	-25.47%0.3687	-15.35%0.3203	2.24%0.2551	13.51%0.1361	-3.21%0.4947	0.93%0.3784	0.24%0.2495
Diluted earnings per share	-4.09%0.3072	-12.62%0.2229	-5.14%0.1291	-25.47%0.3687	-15.33%0.3203	2.24%0.2551	13.51%0.1361	-3.21%0.4947	0.91%0.3783	0.24%0.2495
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	Unqualified Opinion	--	--
Auditor	--	--	--	Deloitte Guan Huang Chen Fang Certified Public Accountants	--	--	--	Deloitte Touche Tohmatsu	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

No. Symbol 5D % Chg

Hong Kong stocks continue to recover! The Hang Seng Index briefly returned to 26,000 points.

Recently, Hong Kong stocks have rebounded from their lows, with the three major indices continuing their upward momentum. The Hang Seng Inde Show More

年頭旺到年尾

Aug 21, 2025 06:11

Are you foolish? What's the point of knowing your mistakes?

牛牛課堂

Sep 12, 2025 17:29

[Opportunity Express] With stock prices soaring, should SMIC "take profits and exit" or "patiently hold on"?